Diffuse Large B-cell lymphoma |
Ly1, Ly3, Ly10, Ly18, Ly19 |
Up |
SMAD5 |
TGF-beta signaling pathway |
Overexpression of hsa-miR-155 downregulates the expression of SMAD5, establishing a link between this miRNA, the TGF-beta signaling pathway, and lymphomagenesis. |
Rai et al., 2010 |
Diffuse Large B-cell lymphoma |
CRL2631 |
Up |
PIK3R1 |
PI3K-Akt signaling pathway |
Overexpression of miR-155 activates PI3K-Akt signaling pathway through regulating PIK3R1 in in diffuse large B-cell lymphoma. |
Huang et al., 2012 |
Malignant lymphoma |
Lymphoma cell lines |
Down |
DKC1 |
PI3K-Akt signaling pathway |
miR-150 directly targets DKC1, reduces levels of phosphorylated AKT and increases levels of tumor suppressors such as Bim and p53. Downregulation of hsa-miR-150 induces continuous activation of the PI3K-PI3K-Akt signaling pathway, leading to telomerase activation and immortalization of cancer cells. |
Watanabe et al., 2011 |
Malignant lymphoma |
Lymphoma cell lines |
Down |
AKT |
PI3K-Akt signaling pathway |
miR-150 directly targets AKT2, reduces levels of phosphorylated AKT and increases levels of tumor suppressors such as Bim and p53. Downregulation of hsa-miR-150 induces continuous activation of the PI3K-PI3K-Akt signaling pathway, leading to telomerase activation and immortalization of cancer cells. |
Watanabe et al., 2011 |
T-cell acute lymphoblastic leukemia |
MOLT-3, Jurkat, CCRF-HSB-2 |
Up |
NOTCH3 |
Notch signaling pathway |
Overexpression of miR-150 downregulates the expression of NOTCH3 and has adverse effects on proliferation and survival T-cell acute lymphoblastic leukemia. |
Ghisi et al., 2011 |
Chronic lymphocytic leukemia |
MEC-2, BJAB |
Up |
QKI |
LPS signaling pathway |
miR-155 down-regulates expression of QKI at the onset of immune response to LPS. Overexpression of QKI increases IL-10 production, as well as the total amount of p38, while markedly impairing p38 phosphorylation. |
Tili et al., 2015 |
Chronic lymphocytic leukemia |
Peripheral blood |
Down |
MCL1 |
MCL1 pathway |
p53 deletion results in a decrease of miR-15a, leads to an increase expression of Mcl-1 in chronic lymphocytic leukemia. |
Liu et al., 2014 |
B-cell chronic lymphocytic leukemia |
Peripheral blood |
Down |
TP53 |
p53 signaling pathway |
Over-expression of hsa-miR-15a suppresses the expression of TP53 in B-cell chronic lymphocytic leukemia. A microRNA/TP53 feedback circuitry is associated with chronic lymphocytic leukemia pathogenesis. |
Fabbri et al, 2011 |
Chronic lymphocytic leukemia |
Peripheral blood |
Down |
BCL2 |
Apoptosis pathway |
miR-15a downregulates the expression of BCL2 and promotes apoptosis in chronic lymphocytic leukemia. |
Cimmino et al., 2005 |
Parkinson's disease |
HEK293 |
Up |
ALPHA SYNUCLEIN |
mTOR pathway |
MicroRNA-153 protects neurons from cell death by interfering with the MPP+-induced suppression of mTOR signaling pathway. |
Fragkouli et al., 2014 |
Parkinson's disease |
SH-SY5Y |
Up |
NRF2 |
Nrf2 signaling pathway |
MicroRNA-153 directly targets Nrf2-antioxidant network which results an aberrant cellular survival events. |
Narasimhan et al., 2014 |
Post influenza bacterial pneumonia |
- |
Up |
|
IL-17 signaling pathway |
MicroRNA-155 controls host immune response to postviral bacterial pneumonia through IL-23/IL-17 pathway. |
Podsiad et al., 2016 |
Hepatitis C virus infection |
Hepatocyte |
Up |
APC |
Wnt signaling pathway |
Over-expression of microRNA-155 promotes hepatocyte proliferation and tumorigenesis by activating Wnt signaling pathway. |
Zhang et al., 2012 |
Hepatitis C virus infection |
Peripheral blood mononuclear cells |
Down |
|
Toll-like receptor signaling pathway |
HCV infection suppresses the induction of miR-155 by modulating Toll-like receptor signaling pathway. |
El-Ekiaby et al., 2012 |
Gastric cancer |
SC-M1, AGS, NUGC-3, SNU-16, AZ-521, KATO III |
Up |
P53 |
Notch signaling pathway |
Notch1/miR-151-5p axis regulates the progression of gastric cancer cells through targeting p53. |
Hsu et al., 2016 |
Non-small cell lung cancer |
A-549 |
|
TLR1 |
NF-Kappa B signaling pathway |
MicroRNA-15a increases radiation sensitivity through NF-Kappa B signaling pathway by targeting TLR1. |
Lan et al., 2015 |
Hepatocellular carcinoma |
BEL-7402, Hep-G2, SMMC-7721 |
Up |
ARID2 |
PI3K-Akt signaling pathway |
MicroRNA-155 enhances tumor growth in hepatocellular carcinoma by inhibiting ARID2-mediated Akt phosphorylation pathway. |
Zhang et al., 2016 |
Breast cancer |
MCF-7, SK-BR-3 |
Up |
SOCS6 |
Jak-STAT signaling pathway |
MicroRNA-155 promotes TAM resistance in breast cancer by regulating SOCS6-STAT3 signaling pathway. |
Shen et al., 2015 |
Ovarian cancer |
SK-OV-3, SNU-119 |
|
|
PI3K-Akt signaling pathway |
Decreased expression of miRNA-150 enhances pertuzumab resistance in ovarian cancer cells through AKT activation. |
Wuerkenbieke et al., 2015 |
Breast cancer |
MCF-7 |
Up |
|
MAPK signaling pathway |
Upregulation of microRNA-155 enhances tumorigenesis through modulating mitogen activated protein kinase signaling pathway. |
Martin et al., 2014 |
Hepatocellular carcinoma |
Hepatocyte |
Up |
WWOX |
Wnt signaling pathway |
Overexpression of hsa-miR-153 downregulates WWOX, a tumor suppressor and inhibitor of Wnt signaling pathway in hepatocellular carcinoma. |
Hua et al., 2015 |
Ovarian cancer |
SK-OV-3, SNU-119 |
Down |
|
PI3K-Akt signaling pathway |
Decreased expression of miRNA-150 regulates the pertuzumab resistance in ovarian cancer through PI3K-Akt signaling pathway. |
Wuerkenbieke et al., 2015 |
Bladder cancer |
UM-UC-3, T24 |
Up |
DMTF1 |
p53 signaling pathway |
MicroRNA-155 acts as a tumor promoter by inhibiting DMTF1 expression in bladder cancer. |
Peng et al., 2015 |
Myocarditis |
Myocardial |
Up |
REL A |
NF-Kappa B signaling pathway |
hsa-miR-155 reduces cardiac injury by repressing NF-Kappa B signaling pathway during acute viral myocarditis. |
Bao et al., 2014 |
Heart failure |
Left ventricular |
Up |
TGFBR1 |
TGF-beta signaling pathway |
Overexpression of hsa-miR-15 inhibits TGF-beta signaling pathway through downregulating the expression of TGFBR1. |
Tijsen et al., 2014 |
Psoriasis |
HaCat |
Up |
PTEN |
PTEN pathway |
Decreased expression of miR-155 significantly inhibits proliferation, migration, invasion and promotes apoptosis through PTEN singaling pathway in psoriasis cells. |
Xu et al., 2017 |
Psoriasis |
HaCat |
Up |
AKT |
PTEN pathway |
MicroRNA-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis. Expression of apoptosis related factor AKT is dramatically changed. |
Xu et al., 2017 |
Psoriasis |
HaCat |
Up |
BCL 2 |
PTEN pathway |
Hsa-miR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway through targeting BCL 2 in the psoriasis. |
Xu et al., 2017 |